Fretz Marjan M, Storm Gert
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Methods Mol Biol. 2010;605:349-59. doi: 10.1007/978-1-60327-360-2_24.
In general, cellular internalization of macromolecular drugs encapsulated in liposomes proceeds via endocytosis. This potentially leads to degradation of the liposome-encapsulated macromolecular content within the endosomal/lysosomal compartment. Therefore, bypassing the endocytic route by conferring a direct plasma membrane translocation property to the liposomes would be very beneficial. Cell penetrating peptides, e.g. TAT-peptide, are exploited in the drug delivery field for their capacity of plasma membrane translocation. Here, we describe the preparation of TAT-peptide modified liposomes and their cellular interaction using live cell flow cytometry and imaging techniques.
一般来说,包裹在脂质体中的大分子药物的细胞内化是通过内吞作用进行的。这可能导致内体/溶酶体区室内脂质体包裹的大分子内容物降解。因此,赋予脂质体直接的质膜转位特性以绕过内吞途径将非常有益。细胞穿透肽,如TAT肽,因其质膜转位能力而被用于药物递送领域。在此,我们描述了TAT肽修饰脂质体的制备及其使用活细胞流式细胞术和成像技术的细胞相互作用。